middle.news

Memphasys Validates RoXsta™ System, Unlocking New Diagnostic Frontiers

8:44am on Thursday 16th of January, 2025 AEDT Biotechnology
Read Story

Memphasys Validates RoXsta™ System, Unlocking New Diagnostic Frontiers

8:44am on Thursday 16th of January, 2025 AEDT
Key Points
  • Manuscript on RoXsta™ accepted by prestigious journal Antioxidants
  • System validated for rapid, precise oxidative stress profiling in human and animal fluids
  • Potential to improve infertility treatments and livestock productivity
  • Scalable diagnostic tool with broad clinical and agricultural applications
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about Memphasys (ASX:MEM)
OPEN ARTICLE